Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates

Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates

Abstract Background To compare the efficacy of 12-month denosumab treatment on bone mineral density (BMD) and bone turnover markers (BTMs) between treatment-naïve osteoporosis patients with rheumatoid arthritis (RA) and those with previous bisphosphonate (BP) therapy. Methods A total of 36 RA patien...

Cijeli opis

Bibliografski detalji
Glavni autori: Tetsuya Kaneko, Koichi Okamura, Yukio Yonemoto, Chisa Okura, Takahito Suto, Masahiro Tachibana, Hideo Sakane, Makoto Inoue, Hirotaka Chikuda
Format: Članak
Jezik:English
Izdano: Wiley 2019-10-01
Serija:Journal of Experimental Orthopaedics
Teme:
Osteoporosis
Denosumab
Bisphosphonate
Rheumatoid arthritis
Fragility fractures
Online pristup:http://link.springer.com/article/10.1186/s40634-019-0211-7

Internet

http://link.springer.com/article/10.1186/s40634-019-0211-7

Slični predmeti